glp 1 brain Glucagon-like peptide-1 (GLP-1), released from the intestine, informs GLP-1 drugs protect brain health

Geographic and Jurisdictional Disclosure : This article is directed to adult consumers in the United States

The FDA tracks these side effects and looks at patterns, severity, and frequency to help them determine if a new boxed warning needs to be added for a drug

The patients who will do best on these medications over the long term are those who use them within a framework that protects lean mass, supports metabolic health, and addresses the behavioural and physiological underpinnings of weight regain

6(10):e26051 Brown TT, Hurley VB, Rodriguez HP, Lee J, Gupta N, Toolsie G et al (2023) Shared decision-making lowers medical expenditures and the effect is amplified in racially-ethnically concordant relationships